Literature DB >> 26332734

Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4-week, open-label clinical study.

Akemi Tomoda1,2, Shinichiro Takiguchi1,2, Takashi X Fujisawa1, Chiho Yatsuga1,2, Hirokazu Kumazaki1,2, Toru Fujioka1,2, Hitomi Suzuki2, Hideo Matsuzaki1,2, Hirotaka Kosaka1,2, Shiho Tanaka1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26332734     DOI: 10.1111/pcn.12336

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  1 in total

1.  Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Takuya Saito; Yushiro Yamashita; Akemi Tomoda; Takashi Okada; Hideo Umeuchi; Saki Iwamori; Satoru Shinoda; Akiko Mizuno-Yasuhira; Hidetoshi Urano; Izumi Nishino; Kazuhiko Saito
Journal:  BMC Psychiatry       Date:  2020-11-10       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.